TRE may improve insulin sensitivity-related outcomes—including fasting plasma glucose, fasting insulin, HOMA-IR, and QUICKI—as well as HbA1c in women with PCOS, however, current evidence does not demonstrate significant effects on anthropometric measures, lipid metabolism, androgen-related outcomes, or blood pressure.
Yang Yang, Zheng Liu, Jing Zhang· Journal of Clinical Medicine· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.